Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Cole

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Cardiology|December 1, 1991
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)F M Sacks, M A Pfeffer, L Moye', et al.
Metabolism: Clinical and Experimental|October 1, 1996
A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studiesN Srivastava, D Noto, M Averna, et al.
Circulation|May 12, 1998
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trialF M Sacks, L A Moyé, B R Davis, et al.
The American Journal of Clinical Nutrition|February 1, 1992
Differential reduction of plasma cholesterol by the American Heart Association Phase 3 Diet in moderately hypercholesterolemic, premenopausal women with different body mass indexesT G Cole, P E Bowen, D Schmeisser, et al.
Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.
The New England Journal of Medicine|October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsF M Sacks, M A Pfeffer, L A Moye, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Clinical Chemistry and Laboratory Medicine|March 22, 2000
A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United StatesM Nauck, M S Graziani, J Jarausch, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Cardiology|December 1, 1991
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)F M Sacks, M A Pfeffer, L Moye', et al.
Metabolism: Clinical and Experimental|October 1, 1996
A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studiesN Srivastava, D Noto, M Averna, et al.
Circulation|May 12, 1998
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trialF M Sacks, L A Moyé, B R Davis, et al.
The American Journal of Clinical Nutrition|February 1, 1992
Differential reduction of plasma cholesterol by the American Heart Association Phase 3 Diet in moderately hypercholesterolemic, premenopausal women with different body mass indexesT G Cole, P E Bowen, D Schmeisser, et al.
Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.
The New England Journal of Medicine|October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsF M Sacks, M A Pfeffer, L A Moye, et al.
Clinical Chemistry|August 1, 1997
Point: status of lipid and lipoprotein standardizationJ R McNamara, E T Leary, F Ceriotti, et al.
Clinical Chemistry and Laboratory Medicine|March 22, 2000
A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United StatesM Nauck, M S Graziani, J Jarausch, et al.
Pageof 5